Nippon Kayaku. 

$8.44
32
+$0.00+0% Monday 15:31

統計

當日最高
8.44
當日最低
8.44
52週高點
8.9
52週低點
8.44
成交量
300
平均成交量
-
市值
1.35B
本益比
14.07
股息殖利率
2.42%
股息
0.2

即將到來

股息

2.42%股息殖利率
Jun 26
$0.23
Dec 25
$0.20
Jun 25
$0.25
Dec 24
$0.16
Jun 24
$0.15
10年成長
10.69%
5年成長
18.13%
3年成長
13.25%
1年成長
2.22%

財報

30Jul預期
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
下一步
0.17
0.22
0.27
0.32
預期EPS
不適用
實際EPS
不適用

財務

7.86%利潤率
有盈利
2019
2020
2021
2022
2023
2024
2.91B營收
228.48M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 NPKYF 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Nippon Kayaku Co., Ltd. is a global enterprise that, along with its subsidiaries, manufactures and distributes a diverse portfolio of products across various sectors. These core areas include functional chemicals, pharmaceuticals, safety systems, and agrochemicals, serving markets in Japan and worldwide. Established in Tokyo, Japan, in 1916, the company operated as Nihon Kayaku Seizou Co., Ltd. until its rebranding to Nippon Kayaku Co., Ltd. in 1945. Its Functional Chemicals Business segment is a broad supplier of advanced materials. This includes a range of functional materials like epoxy and UV-curable resins, specialized sealants for LCDs and LEDs, maleimide resins, and photoresists and insulating substances crucial for micro-electromechanical systems (MEMS), alongside various cleaning agents and general chemicals. Furthermore, it produces colorants for inkjet, textile, and paper applications, as well as thermal paper materials. The segment also develops catalysts vital for acrylic and methacrylic acid production, and manufactures optical and display components such as polarizing films, inorganic polarizers, and parts for LCDs, projectors, and X-ray analysis. The Pharmaceuticals Business segment focuses on therapeutic solutions, providing oncology drugs (both anti-cancer and cancer-related), biosimilars, and generic medications. It also extends into interventional radiology and cardiovascular treatments. Additionally, the segment supplies bulk drug substances and pharmaceutical intermediates, offers diagnostic agents for cancer, and markets GlycoMark, a key biomarker for managing blood glucose levels in diabetes. Within the Safety Systems Business, Nippon Kayaku manufactures critical components for automotive safety, such as airbag inflators, micro gas generators utilized in seatbelt pretensioning systems, and squibs. The Agrochemicals segment contributes to agricultural productivity and public health through a range of products, including insecticides (for both agriculture and public hygiene), herbicides, and soil fumigants. Beyond its core manufacturing, the company also engages in real estate leasing.
Show more...
執行長
Mr. Atsuhiro Wakumoto
員工
5902
國家
美國
ISIN
JP3694400007

上市

0 Comments

分享你的想法

FAQ

Nippon Kayaku. 今天的股價是多少?
NPKYF 目前價格為 $8.44 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 Nippon Kayaku. 股價表現。
Nippon Kayaku. 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Nippon Kayaku. 的股票以代號 NPKYF 進行交易。
Nippon Kayaku. 的市值是多少?
今天 Nippon Kayaku. 的市值為 1.35B
Nippon Kayaku. 下一次財報日期是什麼時候?
Nippon Kayaku. 將於 July 30, 2026 公布下一次財報。
Nippon Kayaku. 上一季度的財報如何?
NPKYF 上一季度的財報為每股 0.31 USD,預估為 不適用 USD,帶來 不適用 的驚喜。下一季度的預估財報為每股 不適用 USD。
Nippon Kayaku. 去年的營收是多少?
Nippon Kayaku. 去年的營收為 2.91BUSD。
Nippon Kayaku. 去年的淨利是多少?
NPKYF 去年的淨收益為 228.48MUSD。
Nippon Kayaku. 會發放股息嗎?
是的,NPKYF 的股息每 半年一次 發放一次。每股最新股息為 0.2 USD。截至今日,股息殖利率(FWD)% 為 2.42%。
Nippon Kayaku. 有多少名員工?
截至 June 20, 2026,公司共有 5,902 名員工。
Nippon Kayaku. 位於哪個產業?
Nippon Kayaku.從事於Materials產業。
Nippon Kayaku. 何時完成拆股?
Nippon Kayaku. 最近沒有進行任何拆股。
Nippon Kayaku. 的總部在哪裡?
Nippon Kayaku. 的總部位於 美國 的 Tokyo。